β-Arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 4, 2015, Pages 3785-3793

  Qiu, Chen ^a   Zheng, Chunlong ^a   Zhu, Linhai ^a   Qu, Xiao ^a   Shen, Hongchang ^a   Du, Jiajun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Lung adenocarcinoma; Prognosis; VEGF; Arrestin1

Indexed keywords

ARRB1 PROTEIN, HUMAN; BETA ARRESTIN; BETA ARRESTIN 1; RETINA S ANTIGEN; TUMOR MARKER; VASCULOTROPIN A;

ADENOCARCINOMA; AGED; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADENOCARCINOMA; AGED; ARRESTINS; BETA-ARRESTIN 1; BETA-ARRESTINS; BIOMARKERS, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84935421370     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL and Karin M. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009; 457: 102-106.
3. Claing A, Laporte SA, Caron MG and Lefkowitz RJ. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol 2002; 66: 61-79.
4. Lefkowitz RJ and Whalen EJ. beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 2004; 16: 162-168.
5. Benmerah A. Endocytosis: signaling from endocytic membranes to the nucleus. Curr Biol 2004; 14: R314-316.
6. Shi Y and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700.
7. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM and DuBois RN. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A 2006; 103: 1492-1497.
8. Shenoy SK, Han S, Zhao YL, Hara MR, Oliver T, Cao Y and Dewhirst MW. beta-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression. Oncogene 2012; 31: 282-292.
9. Zou L, Yang R, Chai J and Pei G. Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis. FASEB J 2008; 22: 355-364.
10. Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Worldwide Esophageal Cancer Colla-boration. Cancer Staging Manual Seventh Edition. Cancer 2010; 15: 3763-73.
11. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Statistics Subcommittee of the NCIEWGoCD. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 2005; 23: 9067-9072.
12. Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Morita M, Funa K and Yasumoto K. Expression of deltaNp73 predicts poor prognosis in lung cancer. Clin Cancer Res 2004; 10: 6905-6911.
13. Yamashita T, Uramoto H, Onitsuka T, Ono K, Baba T, So T, So T, Takenoyama M, Hanagiri T, Oyama T and Yasumoto K. Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC. Lung Cancer 2010; 70: 320-328.
14. Remmele W and Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987; 8: 138-140.
15. Zhang H, Qiu J, Ye C, Yang D, Gao L, Su Y, Tang X, Xu N, Zhang D, Xiong L, Mao Y, Li F and Zhu J. ROR1 expression correlated with poor clinical outcome in human ovarian cancer. Sci Rep 2014; 4: 5811.
16. Camp RL, Dolled-Filhart M and Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004; 10: 7252-7259.
17. Lefkowitz RJ, Rajagopal K and Whalen EJ. New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 2006; 24: 643-652.
18. Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, Postovit LM, Mills GB, Babwah AV and Bhattacharya M. Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 2009; 7: 1064-1077.
19. Ge L, Shenoy SK, Lefkowitz RJ and DeFea K. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J Biol Chem 2004; 279: 55419-55424.
20. Zecchini V, Madhu B, Russell R, Pertega-Gomes N, Warren A, Gaude E, Borlido J, Stark R, Ireland-Zecchini H, Rao R, Scott H, Boren J, Massie C, Asim M, Brindle K, Griffiths J, Frezza C, Neal DE and Mills IG. Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. EMBO J 2014; 33: 1365-1382.
21. Liu H, Long J, Zhang PH, Li K, Tan JJ, Sun B, Yu J, Tu ZG and Zou L. Elevated beta-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia. Int J Hematol 2011; 93: 494-501.
22. Wang LG, Su BH and Du JJ. Expression of beta-arrestin 1 in gastric cardiac adenocarcinoma and its relation with progression. Asian Pac J Cancer Prev 2012; 13: 5671-5675.
23. Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M, Zhang M, Bao G, Wang F, Zhang X, Yang R, Fan F, Chen X, Pei G and Ma L. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 2005; 123: 833-847.
24. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S, Marullo S and Benmerah A. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. J Biol Chem 2002; 277: 37693-37701.
25. Wang P, Wu Y, Ge X, Ma L and Pei G. Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem 2003; 278: 11648-11653.
26. Hicklin DJ and Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-1027.
27. Sobolesky PM and Moussa O. The role of beta-arrestins in cancer. Prog Mol Biol Transl Sci 2013; 118: 395-411.